Literature DB >> 26500764

Important considerations for microRNA extraction methods from whole blood and peripheral blood mononuclear cells.

Sadaf Atarod1, Hannah Smith1, Anne Dickinson1, Xiao-Nong Wang1.   

Abstract

MicroRNAs are non-coding RNAs that negatively regulate mRNA expression and play significant roles in both health and disease. Differential microRNA expression has been used to aid diagnosis and discriminate disease stages. The accuracy and reliability of microRNA expression measurement is of utmost importance. For diagnostic investigations, microRNA expression in human peripheral blood is commonly detected using total RNA extracted using different methods. To date, no convincing data have been available showing whether microRNA expression levels are comparable when total RNA has been extracted from whole blood or peripheral blood mononuclear cells (PBMCs). The present study examined miR-146a-5p and miR-155-5p expression using total RNA extracted in parallel from whole blood and PBMCs of 14 healthy volunteers. MicroRNA expression levels were significantly different between whole blood and PBMCs. No significant difference was observed in microRNA expression between fresh and cryopreserved PBMCs (p=0.125 for both). Further observations revealed that gender differences did not influence miR-146a-5p or miR-155-5p expression regardless of using whole blood (p = 0.797 and 1.00 respectively) or PBMC (p = 0.190 and 0.898 respectively). Our results demonstrate that microRNA expression could be subjective to the methods used for total RNA extraction which highlights the importance of using uniform extraction methods.

Entities:  

Year:  2014        PMID: 26500764     DOI: 10.12688/f1000research.4884.1

Source DB:  PubMed          Journal:  F1000Res        ISSN: 2046-1402


  7 in total

1.  Gestational Diabetes is Associated with an Increased Expression of miR-27a in Peripheral Blood Mononuclear Cells.

Authors:  Ognjen Radojičić; Zorana Dobrijević; Dragana Robajac; Nikola Gligorijević; Vesna Mandić Marković; Željko Miković; Olgica Nedić
Journal:  Mol Diagn Ther       Date:  2022-05-16       Impact factor: 4.476

2.  Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.

Authors:  Marianna Alunni-Fabbroni; Leonie Majunke; Elisabeth K Trapp; Marie Tzschaschel; Sven Mahner; Peter A Fasching; Tanja Fehm; Andreas Schneeweiss; Thomas Beck; Ralf Lorenz; Thomas W P Friedl; Wolfgang Janni; Brigitte Rack
Journal:  BMC Cancer       Date:  2018-02-06       Impact factor: 4.430

3.  Whole blood microRNA expression pattern differentiates patients with rheumatoid arthritis, their seropositive first-degree relatives, and healthy unrelated control subjects.

Authors:  Vidyanand Anaparti; Irene Smolik; Xiaobo Meng; Victor Spicer; Neeloffer Mookherjee; Hani El-Gabalawy
Journal:  Arthritis Res Ther       Date:  2017-11-10       Impact factor: 5.156

4.  Plasma MicroRNAs (miR-146a, miR-103a, and miR-155) as Potential Biomarkers for Rheumatoid Arthritis (RA) and Disease Activity in Iranian Patients.

Authors:  Zahra Bagheri-Hosseinabadi; Mohammad Reza Mirzaei; Mohammad Reza Hajizadeh; Fateme Asadi; Mehdi Rezaeian; Mitra Abbasifard
Journal:  Mediterr J Rheumatol       Date:  2021-12-27

Review 5.  The Use of miRNAs in Predicting Response to Neoadjuvant Therapy in Oesophageal Cancer.

Authors:  Cameron C J Lang; Megan Lloyd; Said Alyacoubi; Saqib Rahman; Oliver Pickering; Tim Underwood; Stella P Breininger
Journal:  Cancers (Basel)       Date:  2022-02-24       Impact factor: 6.639

6.  A novel microRNA signature for the detection of melanoma by liquid biopsy.

Authors:  Claudia Sabato; Teresa Maria Rosaria Noviello; Anna Maria Di Giacomo; Elisabetta Ferretti; Alessia Covre; Sandra Coral; Francesca Pia Caruso; Zein Mersini Besharat; Elena Splendiani; Laura Masuelli; Cecilia Battistelli; Alessandra Vacca; Giuseppina Catanzaro; Agnese Po; Andrea Anichini; Michele Maio; Michele Ceccarelli
Journal:  J Transl Med       Date:  2022-10-15       Impact factor: 8.440

7.  MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis.

Authors:  Veronika Hruskova; Romana Jandova; Lucia Vernerova; Herman Mann; Ondrej Pecha; Klara Prajzlerova; Karel Pavelka; Jiri Vencovsky; Maria Filkova; Ladislav Senolt
Journal:  Arthritis Res Ther       Date:  2016-06-02       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.